Cure My Disease

Don't miss your cure!

 Log in / Sign up

New supplement blend may rival glucosamine for knee arthritis relief

NCT ID NCT07717957

Completed Symptom relief Sponsor: BREGO Life Sciences Source: ClinicalTrials.gov ↗

First seen Jul 21, 2026 · Last updated Jul 23, 2026 · Updated 2 times

Summary

This study compares Mobithron, a supplement containing hyaluronic acid, collagen, and Boswellia, to standard glucosamine for easing pain and improving function in people with knee osteoarthritis. Adults aged 50 to 75 with knee osteoarthritis take either Mobithron or glucosamine daily for three months, alongside a rehabilitation program. Researchers measure changes in pain and mobility using standard questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a dietary supplement containing hyaluronic acid, undenatured type II collagen, and Boswellia serrata extract
What this could lead to
If Mobithron proves more effective than glucosamine, it could offer a new option for managing knee osteoarthritis symptoms.
What could go wrong
This is a small, early-stage study with only 34 participants, so results may not apply broadly. As a supplement, its effects may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KNEE OSTEOARTHRITIS

Contacts and locations

Locations

  • International Islamic University Malaysia

    Kuantan, Pahang, 25200, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.